Näytä suppeat kuvailutiedot

Respiratory syncytial virus infections in children 0–24 months of age in the community

Schuez-Havupalo L.; Toivonen L.; Peltola V.; Teros-Jaakkola T.; Waris M.; Mertsola J.; Karppinen S.

dc.contributor.authorSchuez-Havupalo L.
dc.contributor.authorToivonen L.
dc.contributor.authorPeltola V.
dc.contributor.authorTeros-Jaakkola T.
dc.contributor.authorWaris M.
dc.contributor.authorMertsola J.
dc.contributor.authorKarppinen S.
dc.date.accessioned2022-10-28T12:22:07Z
dc.date.available2022-10-28T12:22:07Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/159260
dc.description.abstract<p>Objectives: Respiratory syncytial virus (RSV) is a major cause of hospitalization in young children, but there are little data on RSV infections in early childhood in the community. We conducted a prospective population-based birth-cohort study to determine the rates and characteristics of RSV infections in young children.<br><br>Methods: We followed 923 children for acute respiratory infections (ARIs) from birth to age 24 months with daily diaries and study clinic visits. Nasal swab samples were obtained at the onset of ARIs and analyzed for RSV by RT-PCR and antigen tests. The rates of RSV infections and associated outcomes were estimated.<br><br>Results: RSV was detected in 289 (6%) of 4728 ARIs with a nasal sample. The mean estimated annual rate of RSV infections was 37 (95% confidence interval [CI], 35–38) per 100 children at age 0–24 months. For RSV-associated outcomes, the estimated annual rates per 100 children were 34 (95% CI, 32–37) physician visits, 16 (95% CI, 15–17) antibiotic treatments, 12 (95% CI, 11–13) acute otitis media, and 6 (95% CI, 4–7) wheezing illnesses. The prevalence of RSV was 0.6% in asymptomatic children.<br><br>Conclusions: RSV infections impose a high burden of disease in healthy young children in the community.<br></p>
dc.language.isoen
dc.publisherW.B. Saunders Ltd
dc.titleRespiratory syncytial virus infections in children 0–24 months of age in the community
dc.identifier.urnURN:NBN:fi-fe2021042824323
dc.relation.volume80
dc.contributor.organizationfi=biolääketieteen laitos, yhteiset|en=Institute of Biomedicine|
dc.contributor.organizationfi=lastentautioppi|en=Paediatrics and Adolescent Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, vsshp|
dc.contributor.organizationfi=infektiotautioppi|en=Infectious Diseases|
dc.contributor.organization-code2607313
dc.contributor.organization-code2607306
dc.contributor.organization-code2607100
dc.converis.publication-id43491099
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/43491099
dc.format.pagerange69
dc.format.pagerange75
dc.identifier.jour-issn0163-4453
dc.okm.affiliatedauthorTeros-Jaakkola, Tamara
dc.okm.affiliatedauthorToivonen, Laura
dc.okm.affiliatedauthorMertsola, Jussi
dc.okm.affiliatedauthorWaris, Matti
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorKarppinen, Sinikka
dc.okm.affiliatedauthorSchuz-Havupalo, Linnea
dc.okm.affiliatedauthorPeltola, Ville
dc.okm.discipline3123 Naisten- ja lastentauditfi_FI
dc.okm.discipline3123 Gynaecology and paediatricsen_GB
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1016/j.jinf.2019.09.002
dc.relation.ispartofjournalJournal of Infection
dc.year.issued2020


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot